Production (Stage)
Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.66
-$0.14-7.78%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -82.56% | 337.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -82.56% | 337.29% | |||
| Cost of Revenue | -81.14% | 150.00% | |||
| Gross Profit | -85.54% | 854.55% | |||
| SG&A Expenses | -8.02% | -8.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.67% | -15.38% | |||
| Operating Income | -22.34% | 26.57% | |||
| Income Before Tax | -23.44% | 27.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.44% | 27.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.44% | 27.74% | |||
| EBIT | -22.34% | 26.57% | |||
| EBITDA | -22.38% | 26.64% | |||
| EPS Basic | -23.46% | 31.88% | |||
| Normalized Basic EPS | -23.53% | 31.91% | |||
| EPS Diluted | -23.46% | 31.88% | |||
| Normalized Diluted EPS | -23.53% | 31.91% | |||
| Average Basic Shares Outstanding | -0.05% | 6.06% | |||
| Average Diluted Shares Outstanding | -0.05% | 6.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||